New Pharmacy Automation and Technology Provider JFCRx Brings Analytics and Innovation to Forefront of Pharmacy Operations
Genoa City, Wisconsin— October 2, 2023 — JFCRx, a supplier of pharmacy automation and technology solutions, announces its entrance to the pharmacy automation space. Conceived and operated by a team of pharmacy industry veterans, JFCRx provides pouch and blister adherence packagers, inspection systems, and vial-fillers for the pharmacy market. The company’s mission is to be […]
SoftWriters Celebrates 5th Consecutive Year as a Pittsburgh Top Workplace
PITTSBURGH, PA, September 26, 2023 — SoftWriters, Inc., the industry leader in long-term care (LTC) pharmacy software, proudly announces its continued recognition as a Top Workplace in Pittsburgh. This esteemed accolade, awarded by the Pittsburgh Post-Gazette, marks SoftWriters’ impressive achievement for the fifth consecutive year, including this year’s honor. Scott Beatty, President at SoftWriters […]
Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients
Mumbai, Naples, September 06, 2023: Global pharma major Lupin Limited (Lupin) today forged a unique collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), a pioneer in affordable medicines, and the COPD Foundation, dedicated to enhancing the lives of COPD patients. This collaboration aims to bolster access to healthcare by expanding the availability […]
Fagron Sterile Services US, Recognized by Angels for Change, Project PROTECT
AUSTIN, TEXAS, SEPTEMBER 7th, 2023 – Fagron Sterile Services US (FSS), a prominent 503B Outsourcing Facility, is proud to announce their selection as a recipient of a 2023 Project PROTECT grant awarded by Angels for Change. This accolade recognizes FSS as a dedicated Protector of Dextrose and certifies FSS’s commitment to safeguarding patient and prescriber […]
WBENC Recertifies The Compliance Team
September 14, 2023, Spring House, PA — The Compliance Team (TCT), a nationally recognized, Centers for Medicare & Medicaid Services (CMS) approved accreditation organization, has been awarded certification as a Women’s Business Enterprise and as a Women-Owned Small Business (WOSB) by the Women’s Business Enterprise National Council (WBENC). The Compliance Team has received this designation […]
Introducing a New Line of Safety Blood Collection Devices: Unistik® Venous Blood Collection
Owen Mumford launches a blood collection safety winged set and safety needle portfolio, designed for simple and safe blood collection. Marietta, GA – July 2023: Venous blood collection is an essential procedure used in various medical settings from hospitals and clinics to diagnostic laboratories. Owen Mumford has been pioneering the advancement of medical technology for […]
Lupin Launches Tiotropium Dry Powder Inhaler for the Treatment of COPD in the United States
Mumbai, Baltimore, August 16, 2023: Global pharma major Lupin Limited (Lupin) today announced the launch of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic obstructive pulmonary disease (COPD) in the US. Tiotropium Bromide Inhalation Powder, 18 mcg/capsule is a generic equivalent of Spiriva® HandiHaler® (Tiotropium Bromide Inhalation Powder), 18 mcg/capsule of Boehringer […]
Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
– Key injectable currently on the U.S. FDA shortage list – Received Competitive Generic Therapy approval designation BRIDGEWATER, N.J.–(BUSINESS WIRE)– Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA”) for calcium gluconate in sodium chloride injection, […]
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
– Key ADHD medicine on the U.S. FDA shortage product list – Represents another high-value product approval for Amneal BRIDGEWATER, N.J.–(BUSINESS WIRE)— Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (“FDA”) for lisdexamfetamine dimesylate capsules, 20 […]
Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More
• New Dexcom product with 15-day wear, a cash-pay option and a tailored software experience for people who don’t use insulin is expected to launch in the U.S. in 2024 • Access and availability of Dexcom CGM is expanding globally, with Dexcom G7 now available in 14 countries and the recent launch of Dexcom ONE […]
